People: Pieris Pharmaceuticals Inc (PIRS.OQ)
14 Nov 2018
Mr. Stephen S. Yoder is President, Chief Executive Officer, Director of the Company. He has been appointed to the Company on the closing of the Acquisition of Pieris, Pieris Operating, on December 17, 2014. Pieris, is a former stockholders of Pieris Operating. Prior to joining Pieris Operating, from July 2003 to December 2010 he led the intellectual property and legal departments at MorphoSys AG, a biotechnology company involved in the development and research of antibodies, as General Counsel. Prior to MorphoSys AG, from September 1999 to June 2003 he worked in several Washington, D.C. law firms, specializing in a life sciences intellectual property practice. Mr. Yoder holds degrees in molecular biology and Spanish from Grove City College and a Juris Doctorate, with honors, from The George Washington University Law School. As an attorney, he is licensed to practice before the United States Patent and Trademark Office, and in the jurisdictions of Maryland and Washington, D.C. We believe that Mr. Yoder adds value to our Board of Directors based on his intimate knowledge of our business plans and strategies of our business and his years of experience in the biotechnology and life sciences industry.
|Total Annual Compensation, USD||320,677|
|Restricted Stock Awards, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,658,980|
|Fiscal Year Total, USD||1,979,660|